Alliance Global Partners analyst Ben Haynor downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.
Oxy’s Q4 Earnings Preview: Buffett’s Confidence, What Analysts Expect, Path To Carbon Neutrality
Oxy's financial results reflect lower earnings due to decreased commodity prices, but the company exhibits stability in debt and liquidity ratios, indicating resilience.